Marian, Ali J.

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

Marian, A. J., & Braunwald, E. (2017) · Circulation Research

Cardiomyopathy and Myosin StudiesCardiovascular Effects of Exercise

Cited by 1,403

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet

Cardiomyopathy and Myosin StudiesBlood Pressure and Hypertension Studies

Cited by 1,296

The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy

Chen, S. N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J. T., & Marian, A. J. (2014) · Circulation Research

Hippo pathway signaling and YAP/TAZCardiomyopathy and Myosin Studies

Cited by 275

A transgenic rabbit model for human hypertrophic cardiomyopathy

Marian, A. J., Wu, Y., Lim, D.-S., McCluggage, M., Youker, K., Yu, Q.-T., Brugada, R., DeMayo, F., Quinones, M., & Roberts, R. (1999) · Journal of Clinical Investigation

Cardiomyopathy and Myosin StudiesCardiac Fibrosis and Remodeling

Cited by 181

BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice

Auguste, G., Rouhi, L., Matkovich, S. J., Coarfa, C., Robertson, M. J., Czernuszewicz, G., Gurha, P., & Marian, A. J. (2020) · Journal of Clinical Investigation

Nuclear Structure and FunctionCardiomyopathy and Myosin Studies

Cited by 77

Genetics and Genomics of Single-Gene Cardiovascular Diseases

Marian, A. J., van Rooij, E., & Roberts, R. (2016) · Journal of the American College of Cardiology

Cardiomyopathy and Myosin StudiesGenomics and Rare Diseases

Cited by 48